Evaluation of the 2023 Duke-ISCVID and 2023 Duke-ESC Clinical Criteria for the Diagnosis of Infective Endocarditis in a Multicenter Cohort of Patients With Staphylococcus aureus Bacteremia.

Détails

ID Serval
serval:BIB_DB75393A32ED
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Evaluation of the 2023 Duke-ISCVID and 2023 Duke-ESC Clinical Criteria for the Diagnosis of Infective Endocarditis in a Multicenter Cohort of Patients With Staphylococcus aureus Bacteremia.
Périodique
Clinical infectious diseases
Auteur⸱e⸱s
Papadimitriou-Olivgeris M., Monney P., Frank M., Tzimas G., Tozzi P., Kirsch M., Van Hemelrijck M., Bauernschmitt R., Epprecht J., Guery B., Hasse B.
ISSN
1537-6591 (Electronic)
ISSN-L
1058-4838
Statut éditorial
Publié
Date de publication
20/03/2024
Peer-reviewed
Oui
Volume
78
Numéro
3
Pages
655-662
Langue
anglais
Notes
Publication types: Multicenter Study ; Journal Article
Publication Status: ppublish
Résumé
The Duke criteria for infective endocarditis (IE) diagnosis underwent revisions in 2023 by the European Society of Cardiology (ESC) and the International Society for Cardiovascular Infectious Diseases (ISCVID). This study aims to assess the diagnostic accuracy of these criteria, focusing on patients with Staphylococcus aureus bacteremia (SAB).
This Swiss multicenter study conducted between 2014 and 2023 pooled data from three cohorts. It evaluated the performance of each iteration of the Duke criteria by assessing the degree of concordance between definite S. aureus IE (SAIE) and the diagnoses made by the Endocarditis Team (2018-23) or IE expert clinicians (2014-17).
Among 1344 SAB episodes analyzed, 486 (36%) were identified as cases of SAIE. The 2023 Duke-ISCVID and 2023 Duke-ESC criteria demonstrated improved sensitivity for SAIE diagnosis (81% and 82%, respectively) compared to the 2015 Duke-ESC criteria (75%). However, the new criteria exhibited reduced specificity for SAIE (96% for both) compared to the 2015 criteria (99%). Spondylodiscitis was more prevalent among patients with SAIE compared to those with SAB alone (10% vs 7%, P = .026). However, when patients meeting the minor 2015 Duke-ESC vascular criterion were excluded, the incidence of spondylodiscitis was similar between SAIE and SAB patients (6% vs 5%, P = .461).
The 2023 Duke-ISCVID and 2023 Duke-ESC clinical criteria show improved sensitivity for SAIE diagnosis compared to 2015 Duke-ESC criteria. However, this increase in sensitivity comes at the expense of reduced specificity. Future research should aim at evaluating the impact of each component introduced within these criteria.
Mots-clé
Humans, Staphylococcus aureus, Discitis, Endocarditis, Bacterial/diagnosis, Endocarditis, Bacterial/epidemiology, Endocarditis/diagnosis, Staphylococcal Infections/diagnosis, Staphylococcal Infections/epidemiology, Bacteremia/diagnosis, Bacteremia/epidemiology, Cardiology, Duke criteria, bacteremia, echocardiography, infective endocarditis
Pubmed
Web of science
Open Access
Oui
Création de la notice
10/01/2024 11:50
Dernière modification de la notice
26/03/2024 8:10
Données d'usage